Auditor25 May 2026, 09:21 pm
Orchid Pharma Appoints Internal Auditor for FY 2026-27
AI Summary
Orchid Pharma Ltd's board meeting on May 25, 2026, approved the appointment of the Internal Auditor for the financial year 2026-27. The board also approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The results along with auditor reports are available on the company's website.
Key Highlights
- Orchid Pharma appoints Internal Auditor for FY 2026-27.
- Board approves audited standalone & consolidated financial results for FY26.
- M/s. Singhi & Co. issued auditor's reports on financial results.
- Standalone results have an unmodified opinion; consolidated results have a modified opinion.
Price Impact
More from ORCHIDPHAR